Development of Clay Nanoparticles in Pharmaceutical Industry

Kakımdoust S., Kalkan E., Bayhan Y. K., Yousef V., Gharibi B.

NanoEra, cilt.1, sa.2, ss.54-57, 2021 (Hakemli Dergi)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1 Sayı: 2
  • Basım Tarihi: 2021
  • Dergi Adı: NanoEra
  • Sayfa Sayıları: ss.54-57
  • Atatürk Üniversitesi Adresli: Evet

Özet

Nanotechnology has grown significantly in the medical field in recent years. This new technology, with the synthesis and introduction of a new drug system, has made a huge difference in the discussion of treatment and health. The preparation and production of drugs based on natural and mineral compounds and the drug delivery system to specific organs of the body is an example of this technology in the field of pharmacy. Mineral drugs, unlike chemical drugs, have no negative effects on various organs of the body. Nano-clays - with their unique properties - are an example of mineral drugs that play a very important role in the pharmaceutical industry today. Bentonite is a clay mineral that is mainly composed of smectite minerals. Ionic substitution, ductility, high cation exchange are important properties of smectite minerals. Due to the weak bond between the layers in this group, it is easy to add different molecules and polymers between their layers, and for this reason, the clay minerals of the smectite group are very important in the pharmaceutical industry. Scientists are conducting research to purify, modify and optimize bentonite minerals and obtain mineral drugs compatible with the body's biological system.